FDA Drug Application (021434) for XANAX XR by PHARMACIA AND UPJOHN

Back to FDA Applications sponsored by PHARMACIA AND UPJOHN

Application Number021434
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage0.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameXANAX XR
Active IngredientALPRAZOLAM

Active IngredientCount
List of drugs with Active Ingredient ALPRAZOLAM4


Back to FDA Applications sponsored by PHARMACIA AND UPJOHN